Aptevo Therapeutics Inc. (APVO) Operating cash flow 2016–2025
Aptevo Therapeutics Inc. (APVO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.6MFY2025 · since FY2016: -$36.9M → -$25.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.6M | -7.6% |
| FY2024 | -$23.8M | -102.8% |
| FY2023 | -$11.7M | +44.2% |
| FY2022 | -$21.0M | +3.0% |
| FY2021 | -$21.7M | +26.1% |
| FY2020 | -$29.3M | +30.8% |
| FY2019 | -$42.4M | +17.6% |
| FY2018 | -$51.4M | -23.7% |
| FY2017 | -$41.6M | -12.8% |
| FY2016 | -$36.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More APVO financial trends
APVO RevenueAPVO Net incomeAPVO Net marginAPVO Gross profitAPVO Gross marginAPVO Operating incomeAPVO Operating marginAPVO Free cash flowAPVO Capital expendituresAPVO Return on equityAPVO Stock buybacksAPVO Dividends paidAPVO Total assetsAPVO Total liabilitiesAPVO Shareholders’ equityAPVO overview →